Healthcare

Langhorne, Pa. – October 13, 2026 -- Perspecta has launched a redesigned version of its ProviderDirectoryAI (PDAI) solution, adding list, map and card views and client-specific member content to a search tool used by health plans, workers' compensation teams and provider organizations.

The redesign extends existing provider search capabilities and targets users on mobile, tablet and desktop. Perspecta says it built the update from client and end-user feedback.

PDAI adds three search views and distance-based sorting

Users can switch between list, map and card views. Healthcare professionals can review detailed provider information, while members can compare options and find providers close to home or work. Interactive maps and distance-based sorting show where providers are located.

San Francisco – October 12, 2026 -- Avive Solutions will supply five Avive Connect AEDs along the course of the 36th Walk for Life & Famously Hot Pink 10K + 5K in Columbia, South Carolina, as the event's first aid sponsor. The race, presented by Prisma Health Midlands Foundation, takes place Saturday, October 17, 2026.

Medical volunteers will carry the defibrillators on the route

Event medical volunteers will carry the five devices along the course, so trained professionals have them at hand during a cardiac emergency. Jeffery Faw, the foundation's Executive Director and Chief Development Officer, said the event draws thousands of participants each year and that the devices give the medical team current technology for such an emergency.

Birmingham, Ala. – October 12, 2026 -- Eighty-seven percent of employers say they are likely to switch their pharmacy benefit manager (PBM) at contract renewal, according to a new RxBenefits report that describes the most unsettled pharmacy benefits market in years.

The report, "2026 State of Pharmacy Benefits Decisions: The Churn Trap," draws on survey data fielded by FTI Consulting on behalf of RxBenefits. It covers 601 employers and 300 employee benefits consultants and advisors, all with decision-making authority over pharmacy benefits.

Three in four employers have changed or plan to change advisors within 12 months

Three out of four employers have replaced their pharmacy benefits advisor in the past 12 months or plan to do so in the next 12 months. RxBenefits says the advisor relationships and vendor arrangements that once anchored pharmacy decisions are losing their hold.

Atlanta – October 12, 2026 -- Colquitt Regional Health System in Moultrie, Georgia, is the subject of an upcoming Public Television segment on how a South Georgia hospital used graduate medical education and expanded specialty services to build a regional training and care hub.

All Access crews filmed the Moultrie segment on September 21, 2026

The segment comes from "All Access hosted by Andy Garcia," an independent short-form documentary series produced for Public Television stations nationwide. It examines how localized investment affects patient outcomes and covers data diversity and local workforce development in rural health networks. Targeted facility expansions and intentional culture shifts are presented as the factors that attract top medical talent.

San Carlos – October 12, 2026 -- Noah Medical will present published results showing 100% tool-in-lesion accuracy and diagnostic yield of 89.5% (strict) to 94.7% (intermediate) for its Galaxy System robotic bronchoscopy platform at AABIP 2024 in Charlotte, North Carolina, August 22-24.

Published data show 100% navigation to small peripheral lesions

Results from Saghaie et al. (2024) report 100% successful navigation to small lesions in the lung periphery. The Galaxy System combines proprietary integrated tomosynthesis (TiLT+ Technology) with augmented fluoroscopy and tool-in-lesion confirmation.

San Carlos – October 12, 2026 -- Noah Medical's Galaxy System achieved a 96.7% overall diagnostic yield under a strict definition in the MATCH 2 study, now published online ahead of print in the peer-reviewed journal Respiratory Medicine.

Study tested imaging-guided targeting in 31 patients with peripheral nodules

Thirty-one patients with peripheral pulmonary nodules underwent robotic-assisted bronchoscopy (RAB) with the Galaxy System. Researchers evaluated three-dimensional targeting accuracy using embedded digital tomosynthesis (DT) and integrated augmented fluoroscopy (AF). Cone-beam computed tomography (CBCT), which provides volumetric lung imaging during procedures, was used to confirm tool-in-lesion (TIL) placement.

St. Paul – October 12, 2026 -- Solventum (NYSE: SOLV) will take part in a virtual fireside chat at the 2026 KeyBanc Healthcare Forum on Wednesday, March 18, 2026, starting at approximately 10:30 a.m. EDT.

Solventum management will appear in a virtual format at the investor event

The session is a fireside chat, a Q&A-style discussion, and will be held online rather than in person. The company has not named which executives will take part.

A live webcast and a replay will be available through the investor relations site at investors.solventum.com.

The announcement did not mention financial guidance, product updates or other disclosures planned for the session.

Eagan – October 12, 2026 -- Solventum (NYSE: SOLV) will publish its second quarter fiscal 2026 financial results on Wednesday, August 5, 2026, after U.S. financial markets close.

Management to host webcast after the release

Solventum management will hold a webcast following the release to discuss the results. The company said other forward-looking and material information may also be covered during the call, so the session could contain disclosures beyond the quarterly figures.

Replay, slides and supplemental data to go online

A webcast replay, the earnings press release, presentation slides and supplemental financial disclosures will be available in the Investor Relations section of Solventum's website.

The announcement did not include financial guidance or preliminary figures for the quarter.

Eagan, Minnesota – October 12, 2026 -- Solventum (NYSE: SOLV) will present at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, with management taking part in a fireside chat beginning at approximately 10:15 a.m. EDT in Boston, Massachusetts.

Solventum management gets a 10:15 a.m. EDT slot in Boston on Sept. 9

The company announced the appearance on Sept. 2, 2026, one week before the session. The announcement did not name the executives who will take part or list agenda topics.

A live webcast and an archived replay of the fireside chat will be available on the company's investor relations website, giving investors who cannot attend in Boston access to the discussion.

Toronto – October 12, 2026 -- Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) will report its second quarter 2026 financial results after market close on Thursday, August 6, 2026.

Management hosts call at 4:30 p.m. ET on results day

The interventional MRI (iMRI) company will hold a conference call at 4:30 p.m. ET on August 6 to review the quarter's results and discuss business developments in the period. Investors must register in advance for the live call.

Two MRI-guided platforms drive the commercial portfolio

Profound markets TULSA-PRO, which is FDA-cleared in the United States for transurethral ultrasound ablation (TULSA) of prostate tissue. The system is also cleared in Europe, Canada, Saudi Arabia, India, Australia/New Zealand and the UAE.